ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare ConferenceHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare ConferencePR NewswireJanuary 2, 2020ReblogShareTweetShareSOUTH SAN FRANCISCO, Calif., Jan. 2, 2020 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob Chacko, MD, the Company's Chief Executive Officer, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference. Dr. Chacko's presentation will take place on Tuesday, January 14, 2020, at 9:30 a.m. PST.About ORIC PharmaceuticalsORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance. ORIC's lead program, ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to treatment resistance to multiple classes of anti-cancer therapeutics across a variety of solid tumors.  ORIC's pipeline also includes an orally bioavailable small molecule inhibitor of CD73, as well as other undisclosed programs targeting mechanisms of oncology therapeutic resistance. ORIC's scientific founders, Charles Sawyers, MD, and Scott Lowe, PhD, have long records of discovering novel targets in cancer that have led to innovative treatments. The company has assembled strong leadership and scientific teams, and a board with extensive experience in drug development and financing. ORIC is funded by leading biotechnology investors and is headquartered in South San Francisco, California. For more information, please go to http://oricpharma.com/.Contact:Dominic Piscitelli, Chief Financial Officer  231680@email4pr.com 650-388-5600CisionMoreView original content:http://www.prnewswire.com/news-releases/oric-pharmaceuticals-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300980212.htmlSOURCE ORIC PharmaceuticalsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextDicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue EstimatesZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoInvestors in Asia Still Betting Markets Will End Higher in 2020BloombergDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoThyssenkrupp sells elevator unit for $18.7 billion to Advent, Cinven consortiumReutersStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceMost romantic destinations in North America ranked: The Points GuyYahoo Finance VideoUnited pulls Boeing's 737 Max jets through June 2020Yahoo Finance Video